Skip to content

144Accepted Oct 16, 5:35 PM ET

Janux Therapeutics, Inc. 144

Avalon BioVentures I, LP

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:35 PM

Oct 16, 2024

Filed

Oct 16, 2024

Documents

1

Size

7.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.